Core Viewpoint - The integration of AI technology is driving a transformation in the traditional Chinese medicine (TCM) industry in Guangdong, with the establishment of two specialized committees focusing on classic prescriptions and the synergy between medicine and food [1][4]. Group 1: Industry Development and Achievements - The Guangdong Provincial Chinese Medicine Association held its second member representative conference, emphasizing the theme "AI Empowering New Business Formats, Leading New TCM" [2][3]. - The TCM industry in Guangdong has seen steady growth, with over 370 TCM production enterprises and more than 4,780 approved TCM products as of the end of 2025 [10][11]. - The province has approved 7 new TCM drugs and added 8 new national TCM protected varieties, maintaining a strong position nationally [12]. Group 2: Key Initiatives and Standards - During the "14th Five-Year Plan" period, Guangdong has implemented five key measures to strengthen the industry foundation, including the compilation of standards for TCM materials and the release of 479 standards for granule prescriptions [15][16]. - The establishment of the "Quality Management Norms for TCM Distribution and Preparation Bases" aims to address the growing demand for TCM preparation and distribution services [39][40]. Group 3: AI and Technological Integration - The conference highlighted the deep integration of AI and genomics in TCM innovation, with significant breakthroughs presented by experts in the field [26][27]. - The development of a gene coding library for natural drug components is expected to enhance the precision and efficiency of new drug screening [28][29]. Group 4: Specialized Committees and Collaborative Efforts - Two specialized committees were established: one for classic prescriptions and another for the synergy between medicine and food, aimed at promoting industry development and standardization [33][34]. - The committees are expected to facilitate practical research and industry assessments, contributing to the growth of the TCM sector in Guangdong [36][38]. Group 5: Future Directions and Goals - The Guangdong Provincial Drug Administration is leading the formulation of policies for high-quality development in the pharmaceutical and medical device industries, with a focus on AI applications in drug regulation [21][22]. - The association aims to continue serving as a bridge for the industry, focusing on innovation and quality as it moves into the new development phase of the "14th Five-Year Plan" [64][66].

Core Viewpoint - Heilongjiang Province is focusing on enhancing public safety through innovative regulatory measures during the "14th Five-Year Plan" period, particularly in food, drug, key industrial products, and special equipment safety [1][3]. Group 1: Food Safety - The market regulation system in Heilongjiang is implementing comprehensive supervision to ensure food safety, particularly in key areas such as school meals, infant formula, meat products, counterfeit food in rural areas, and online dining [3]. - A total of 3,588 "You Point, I Test" activities have been conducted, and over 160,000 food-related complaints have been processed, strengthening the collaborative governance of food safety [3]. Group 2: Industrial Product Safety - Since the beginning of the "14th Five-Year Plan," Heilongjiang has conducted quality supervision and random inspections on 135 types of products across 13 categories, with an average compliance rate of 94.46% in the first three quarters of 2025 [4]. - The province has discovered and resolved nearly 110,000 safety defects and technical issues through safety assessments and expert assistance, significantly improving the safety level of special equipment [3][4]. Group 3: Drug Safety - A list-based management mechanism has been established for drug regulation, with a total of 46,354 drug samples tested, achieving a high compliance rate of 99.88%, ensuring public confidence in medication safety [4]. - The province is exploring an "AI + drug regulation" model to enhance the precision and effectiveness of drug safety oversight [4]. Group 4: Future Directions - Heilongjiang's market regulation department plans to continue deepening regulatory innovations and strengthening technological empowerment to solidify the achievements in the "four safety" guarantees, supporting high-quality economic and social development in the province [4].